文献詳細
今月の主題 家族性大腸腺腫症―最近の話題
主題
文献概要
要旨 sulindac,indomethacin,celecoxibなどの非ステロイド抗炎症剤は家族性大腸腺腫症患者の大腸腺腫を退縮させる効果を有するものの,その効果は完全とは言えない.また,これらの薬剤の大腸癌そのものの予防効果については検討されていない.したがって,現時点でこれらの非ステロイド抗炎症剤は結腸全摘や大腸全摘に替わる治療法ではない.しかし,非ステロイド抗炎症剤などの薬剤の中には,大腸癌予防に有効な薬剤が存在する可能性もあり,更なる検討を要する.また,大腸腺腫退縮の機序の詳細はまだ解明されておらず,その解明はFAPのみならず一般の大腸癌の予防法の確立にも役立つ可能性がある.
参考文献
1)Kudo T, Narisawa T, Abo S. Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. Gann 71 : 260-264, 1980
2)Narisawa T, Sato M, Tani M, et al. Inhibition of development of methylnitrosourea induced rat colon tumors by indomethacin treatment. Cancer Res 41 : 1954-1957, 1981
3)Thun MJ, Namboodiri MM, Heath CW. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325 : 1593-1596, 1991
4)Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 24 : 83-87, 1983
5)Giardiello FM, Hamilton S, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328 : 1313-1316, 1993
6)Rigau J, Pique JM, Rubio E, et al. Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med 115 : 952-959, 1991
7)Ishikawa H, Akedo I, Suzuki T, et al. Adverse effects of sulindac used for prevention of colorectal cancer. J Natl Cancer Inst 89 : 1381, 1997
8)Winde G, Schmid KW, Schlegel W, et al. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Dis Colon Rectum 38 : 813-830, 1995
9)Giardiello FM, Yang VW, Hylind LM, et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 346 : 1054-1059, 2002
10)Niv Y, Fraser GM. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 107 : 854-857, 1994
11)Lynch HT, Thorson AG, Smyrk T. Rectal cancer after prolonged sulindac chemoprevention. Cancer 75 : 936-938, 1995
12)Hirata K, Itoh H, Ohsato K. Regression of rectal polyps by indomethacin suppository in familial adenomatous polyposis. Dis Colon Rectum 37 : 943-946, 1994
13)Hirota C, Iida M, Aoyagai K, et al. Effect of indomethacin suppositories on rectal polyposis in patients with familial adenomatous polyposis. Cancer 78 : 1660-1665, 1996
14)Akasu T, Yokoyama T, Sugihara K, et al. Peroral sustained-release indomethacin treatment for rectal adenomas in familial adenomatous polyposis : A pilot study. Hepatogastroenterology 49 : 1259-1261, 2002
15)Vane J. Towards a better aspirin. Nature 367 : 215-216, 1994
16)Eberhart CE, Coffey RJ, Radhika A, et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 : 1183-1188, 1994
17)Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55 : 3785-3789, 1995
knochout mice by inhibition of cyclooxygenase 2(COX -2). Cell 87: 803-809, 1996
19)Kawamori T, Rao CV, Seibert K, et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58 : 409-412, 1998
20)Takahashi M, Fukutake M, Yokota S, et al. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. J Cancer Res Clin Oncol 122 : 219-222, 1996
21)Fukutake M, Nakatsugi S, Isoi T, et al. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis 19 : 1939-1942, 1998
22)Nakatsugi S, Fukutake M, Takahashi M, et al. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice. Jpn J Cancer Res 88 : 1117-1120, 1997
23)Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342 : 1946-1952, 2000
24)Akasu T, Wakabayashi K, Nakatsugi S, et al. Lack of effect of nimesulide, a selective cyclooxygenase-2 inhibitor, on rectal adenomas in familial adenomatous polyposis. submitted.
25)Hawk ET, Umar A, Viner JL. Colorectal cancer chemoprevention―An overview of the science. Gastroenterology 126 : 1423-1447, 2004
26)Kakizoe T. Chemoprevention of cancer-focusing on clinical trials. Jpn J Clin Oncol 33: 421-442, 2003
掲載誌情報